Xu G, Zheng M, Wu Z, Xie T, et al. Entinostat overcomes cisplatin resistance in bladder cancer by promoting H3K18la-mediated DHRS2 expression and nuclear translocation to suppress the AKR1C3-androgen axis. Drug Resist Updat 2025;85:101343.
PMID: 41401485